Tech Company Financing Transactions
Allorion Therapeutics Funding Round
Allorion Therapeutics secured a $50 million Series B funding round on 3/10/2023. Investors included INCE Capital, Qiming Ventures and 3SBio.
Transaction Overview
Company Name
Announced On
3/10/2023
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors
INCE Capital (Lead Investor)
Qiming Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance upcoming Phase I/II clinical trials in both China and the U.S. and the identification of clinical candidates for additional programs, and its established and validated early discovery platform technologies, including an allosteric inhibitor screening platform and a platform for discovery of synthetic lethality targets and molecules, and further build clinical development and business development teams.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
22 Strathmore Rd,
Natick, MA 01760
USA
Natick, MA 01760
USA
Phone
Undisclosed
Website
Email Address
Overview
At Allorion Therapeutics, we focus on developing novel small molecule drugs against cancer and autoimmune diseases. Our team is comprised of experts in cancer biology and drug development. The fields we want to dive into include: selecting well-validated targets with clear clinic development routes and discovering their modulators with distinct mechanisms of actions, building our innovative data and screening platforms for sustainable success,constructing chemical libraries with priorities on allosteric and covalent modulators and optimizing the libraries through the aid of AI.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Qiang Ding
Chief Scientific Officer
Fang Li
Co-Founder
Dai Cheng
Browse more venture capital transactions:
Prev: 3/10/2023: Cubist venture capital transaction
Next: 3/10/2023: Luru venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs